Literature DB >> 2929214

Monoclonal antibodies (MAb 17-1A) for the treatment of patients with metastatic colorectal carcinomas.

H Mellstedt1, J E Frödin, G Masucci, C Lindemalm, C Wedelin, B Christensson, J Shetye, P Biberfeld, A K Lefvert, P Pihlstedt.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2929214

Source DB:  PubMed          Journal:  Acta Chir Scand Suppl        ISSN： 0301-1860


× No keyword cloud information.
  3 in total

1.  Documenting the natural history of patients with resected stage II adenocarcinoma of the colon after random assignment to adjuvant treatment with edrecolomab or observation: results from CALGB 9581.

Authors:  Donna Niedzwiecki; Monica M Bertagnolli; Robert S Warren; Carolyn C Compton; Nancy E Kemeny; Al Bowen Benson; S Gail Eckhardt; Steven Alberts; Gity N Porjosh; David J Kerr; Anthony Fields; Philippe Rougier; J Marc Pipas; Joel H Schwartz; James Atkins; Mark O'Rourke; Michael C Perry; Richard M Goldberg; Robert J Mayer; Thomas A Colacchio
Journal:  J Clin Oncol       Date:  2011-07-11       Impact factor: 44.544

2.  Dose-related comparison of antibody-dependent cellular cytotoxicity with chimeric and native murine monoclonal antibody 17-1A. Improved cytolysis of pancreatic cancer cells with chimeric 17-1A.

Authors:  Y Haga; C L Sivinski; D Woo; M A Tempero
Journal:  Int J Pancreatol       Date:  1994-02

Review 3.  Monoclonal antibodies in imaging and therapy of colorectal cancer.

Authors:  M K Lange; E W Martin
Journal:  World J Surg       Date:  1991 Sep-Oct       Impact factor: 3.352
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.